Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter

Biochemical Journal

Volumn 388, Issue 3, 2005, Pages 913-920

  Xiao, Qingli ^a   Hsu, Chung Y ^a,b   Chen, Hong ^a   Ma, Xiucui ^a   Xu, Jan ^a   Lee, Jin Moo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

cis regulatory element; Electrophoretic mobility shift assay; Gene promoter; Gene regulation; Transcription factor; Vascular endothelial growth inhibitor

Indexed keywords

BIOCHEMISTRY; CHARACTERIZATION; CLONING; PROTEINS; TUMORS;

ANGIOGENESIS; CEREBRAL ENDOTHELIAL CELLS; CEREBRAL ENDOTHERMIC CELLS; CIS-REGULATORY ELEMENTS; TUMOR GROWTH; VASCULAR ENDOTHELIAL GROWTH INIBITOR (VEGI);

GENES;

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PROTEIN P50; SYNAPTOTAGMIN; TATA BINDING PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BRAIN; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; GENE DELETION; GLIOMA CELL; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX; TRANSCRIPTION INITIATION; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; EXONS; GENE EXPRESSION REGULATION; INTRONS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RATS; RESPONSE ELEMENTS; SEQUENCE ANALYSIS, DNA; TELENCEPHALON; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21744449474     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041739     Document Type: Article

References (48)

1. Zhai, Y., Ni, J., Jiang, G. W., Lu, J., Xing, L., Lincoln, C., Carter, K. C., Janat, F. Kozak, D., Xu, S. et al. (1999) VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 13, 181-189
2. Yue, T. L., Ni, J., Romanic, A. M., Gu, J. L., Keller, P., Wang, C., Kumar, S., Yu, G. L., Hart, T. K., Wang, X. et al. (1999) TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J. Biol. Chem. 274, 1479-1486
3. Tan, K. B., Harrop, J., Reddy, M., Young, P., Terrett, J., Emery, J., Moore, G. and Truneh, A. (1997) Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoletic cells. Gene 204, 35-46
4. Chew, L. J., Pan, H., Yu, J., Tian, S., Huang, W. Q., Zhang, J. Y., Pang, S. and Li, L. Y. (2002) A novel secreted splice variant of vascular endothelial cell growth inhibitor. FASEB J. 16, 742-744
5. Zhai, Y., Yu, J., Iruela-Arispe, L., Huang, W., Wang, Z., Hayes, A., Lu, J., Jiang, G. W., Rojas, L., Lippman, M. E. et al. (1999) Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily. Int. J. Cancer 82, 131-136
6. Yu, J., Tian, S., Metheny-Barlow, L., Chew, L. J., Hayes, A. J., Pan, H. G., Yu, G. L. and Li, L. Y. (2001) Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor. Circ. Res. 89, 1161-1167
7. Haridas, V., Shrivastava, A., Su, J., Yu, G. L., Ni, J., Liu, D., Chen, S. F., Ni, Y., Ruben, S. M., Gentz, R. et al. (1999) VEGI, a new member of the TNF family activates nuclear factor-κB and c-Jun N-terminal kinase and modulates cell growth. Oncogene 18, 6496-6504
8. Migone, T. S., Zhang, J., Luo, X., Zhuang, L., Chen, C., Hu, B., Hong, J. S., Perry, J. W., Chen, S. F., Zhou, J. X. et al. (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479-492
9. Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V. and Boldin, M. P. (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331-367
10. Baldwin, Jr, A. S. (1996) The NF-κ and lκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683
11. Fan, C. M. and Maniatis, T. (1991) Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature (London) 354, 395-398
12. Orian, A., Whiteside, S., Israel, A., Stancovski, I., Schwartz, A. L. and Ciechanover, A. (1995) Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. J. Biol. Chem. 270, 21707-21714
13. Coope, H. J., Atkinson, P. G., Huhse, B., Belich, M., Janzen, J., Holman, M. J., Klaus, G. G., Johnston, L. H. and Ley, S. C. (2002) CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J. 21, 5375-5385
14. Malek, S., Huxford, T. and Ghosh, G. (1998) lκ-Bα functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-κB. J. Biol. Chem. 273, 25427-25435
15. Simeonidis, S., Stauber, D., Chen, G., Hendrickson, W. A. and Thanos, D. (1999) Mechanisms by which lκB proteins control NF-κB activity. Proc. Natl. Acad. Sci. U.S.A. 96, 49-54
16. Madge, L. A. and Pober, J. S. (2000) A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human endothelial cells. J. Biol. Chem. 275, 15458-15465
17. Johnson, D. R., Douglas, I., Jahnke, A., Ghosh, S. and Pober, J. S. (1996) A sustained reduction in lκB-β may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. 271, 16317-16322
18. Spiecker, M., Darius, H. and Liao, J. K. (2000) A functional role of lκB-ε in endothelial cell activation. J. Immunol. 164, 3316-3322
19. Huang, S., Robinson, J. B., Deguzman, A., Bucana, C. D. and Fidler, I. J. (2000) Blockade of nuclear factor-κB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 60, 5334-5339
20. Minami, T. and Aird, W. C. (2001) Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-κB and GATA motifs. J. Biol. Chem. 276, 47632-47641
21. Takeuchi, M. and Baichwal, V. R. (1995) Induction of the gene encoding mucosal vascular addressin cell adhesion molecule 1 by tumor necrosis factor α is mediated by NF-κB proteins. Proc. Natl. Acad. Sci. U.S.A. 92, 3561-3565
22. Karashima, T., Sweeney, P., Kamat, A., Huang, S., Kim, S. J., Bar-Eli, M., McConkey, D. J. and Dinney, C. P. (2003) Nuclear factor-κB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin. Cancer Res. 9, 2786-2797
23. Whelan, J., Ghersa, P., Hooft van Huijsduijnen, R., Gray, J., Chandra, G., Talabot, F. and DeLamarter, J. F. (1991) An NFκB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 19, 2645-2653
24. Yin, K. J., Lee, J. M., Chen, S. D., Xu, J. and Hsu, C. Y. (2002) Amyloid-β induces Smac release via AP-1/Bim activation in cerebral endothelial cells. J. Neurosci. 22, 9764-9770
25. Xu, J., Wu, Y., He, L., Moore, S. A. and Hsu, C. Y. (1997) Regulation ot cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells. Biochem. Biophys. Res. Commun. 235, 394-397
26. Mathew, S., Murty, V. V., Dalla-Favera, R. and Chaganti, R. S. (1993) Chromosomal localization of genes encoding the transcription factors, c-rel, NF-κB p50, NF-κB p65, and lyt-10 by fluorescence in situ hybridization. Oncogene 8, 191-193
27. Ghosh, S., May, M. and Kopp, E. (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260
28. Thanos, D. and Maniatis, T. (1995) NF-κB: a lesson in family values. Cell (Cambridge, Mass.) 80, 529-532
29. Baeuerle, P. A. and Baltimore, D. (1996) NF-κB: ten years after. Cell (Cambridge, Mass.) 87, 13-20
30. Plaksin, D., Baeuerle, P. A. and Eisenbach, L. (1993) KBF1 (p50 NF-κB homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells. J. Exp. Med. 177, 1651-1662
31. Tolnay, M., Vereshchagina, L. A. and Tsokos, G. C. (2002) NF-κB regulates the expression of the human complement receptor 2 gene. J. Immunol. 169, 6236-6243
32. Lu, R., Moore, P. A. and Pitha, P. M. (2002) Stimulation of IRF-7 gene expression by tumor necrosis factor α: requirement for NFκB transcription factor and gene accessibility. J. Biol. Chem. 277, 16592-16598
33. Udalova, I. A., Richardson, A., Denys, A., Smith, C., Ackerman, H., Foxwell, B. and Kwiatkowski, D. (2000) Functional consequences of a polymorphism affecting NF-κB p50-p50 binding to the TNF promoter region. Mol. Cell. Biol. 20, 9113-9119
34. Lee, B. H., Kim, M. S., Rhew, J. H., Park, R. W., de Crombrugghe, B. and Kim, I. S. (2000) Transcriptional regulation of fibronectin gene by phorbol myristate acetate in hepatoma cells: a negative role for NF-κB. J. Cell Biochem. 76, 437-451
35. Kim, C. H., Kim, J. H., Hsu, C. Y. and Ahn, Y. S. (1999) Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-κB activation. FEBS Lett. 449, 28-32
36. Machado, Jr, J., Fernandez, P. C., Baumann, I. and Dobbelaere, D. A. (2000) Characterisation of NF-κB complexes in Theileria parva-transformed T cells. Microbes Infect. 2, 1311-1320
37. Qin, Y., Camoretti-Mercado, B., Blokh, L., Long, C. G., Ko, F. D. and Hamann, K. J. (2002) Fas resistance of leukemic eosinophils is due to activation of NF-κB by Fas ligation. J. Immunol. 169, 3536-3544
38. Bian, X., Opipari, Jr, A. W., Ratanaproeksa, A. B., Boitano, A. E., Lucas, P. C. and Castle, V. P. (2002) Constitutively active NFκB is required for the survival of S-type neuroblastoma. J. Biol. Chem. 277, 42144-42150
39. Baeuerle, P. A. and Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179
40. Grossmann, M., Nakamura, Y., Grumont, R. and Gerondakis, S. (1999) New insights into the roles of ReL/NF-κB transcription factors in immune function, hemopoiesis and human disease. Int. J. Biochem. Cell Biol. 31, 1209-1219
41. Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibshi, T., Suzuki, H. and Kuwano, M. (1997) Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis. Mol. Cell. Biol. 17, 4015-4023
42. Giraudo, E., Primo, L., Audero, E., Gerber, H. P., Koolwijk, P., Soker, S., Klagsbrun, M., Ferrara, N. and Bussolino, F. (1998) Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem. 273, 22128-22135
43. Paleolog, E. M., Young, S., Stark, A. C., McCloskey, R. V., Feldmann, M. and Maini, R. N. (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis. Arthritis Rheum. 41, 1258-1265
44. Montrucchio, G., Lupia, E., Battaglia, E., Passerini, G., Bussolino, F., Emanuelli, G. and Camussi, G. (1994) Tumor necrosis factor α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med. 180, 377-382
45. DeBusk, L. M., Chen, Y., Nishishita, T., Chen, J., Thomas, J. W. and Lin, P. C. (2003) Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor α-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum. 48, 2461-2471
46. Chen, J. X., Chen, Y., DeBusk, L., Lin, W. and Lin, P. C. (2004) Dual functional roles of Tie-2/angiopoietin in TNF-α-mediated angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 287, H187-H195
47. Ko, H. M., Seo, K. H., Han, S. J., Ahn, K. Y., Choi, I. H., Koh, G. Y., Lee, H. K., Ra, M. S. and Im, S. Y. (2002) Nuclear factor κB dependency of platelet-activating factor-induced angiogenesis. Cancer Res. 62, 1809-1814
48. Feldmann, M. and Maini, R. N, (2001) Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 119, 163-196